与TTC19相关的线粒体复合物III缺乏症:来自5个无关阿拉伯家庭的10名患者的临床和遗传特征
Malak Alghamdi1, Ahmad Alahmad2, Malak Alaboudi3
1Division of Medical Genetics, Department of Pediatrics, King Saud University, College of Medicine, Riyadh, Saudi Arabia; Department of Pediatrics, King Saud University Medical City Riyadh, Saudi Arabia.
Molecular genetics and metabolism
|March 12, 2026
概括
四重复域19 (TTC19) 基因中的致病变体导致线粒体复合体III缺乏,导致渐进的神经退行. 这项研究在阿拉伯家庭中发现了三种新的TTC19变异,扩大了这种罕见遗传疾病的范围.
科学领域:
- 遗传学 是一个遗传学.
- 神经科学是一个神经科学.
- 生物化学 生化学
背景情况:
- 孤立线粒体复合体III缺乏症是一种罕见的遗传疾病,具有异质的临床表现.
- 四重复域19 (TTC19) 基因中的致病变体是核型线粒体复合体III缺乏症的已知原因 (MIM #615157).
- TTC19变种可能导致渐进的神经退行性疾病.
研究的目的:
- 研究来自阿拉伯家庭的患者队列中线粒体复合物III缺乏症的遗传基础.
- 识别和描述TTC19基因中的新型致病变体.
- 扩大对TTC19相关疾病的表型和基因型谱的理解.
主要方法:
- 来自五个无关阿拉伯家庭的10名患者的临床评估和长期随访.
- 序列神经放射学成像,以评估疾病进展.
- 整体外基因组测序 (ES) 用于识别遗传变异.
- 线粒体功能研究以支持已识别的变体的致病性.
主要成果:
- 外基因组测序在五个家族中发现了三种不同的致病性TTC19变体 (c.680_709del,c.779_780del,c.153_156del).
- 预计这些已识别的变异会导致TTC19蛋白的功能丧失.
- 特定变种显示区域聚类,在三个叙利亚家族中发现了一种复发变种.
- 患有进展性神经退行性疾病的患者,包括失去了行走能力,言语障碍和认知回归.
结论:
- 证实TTC19基因的功能丧失变异是与线粒体复合体III缺乏相关的渐进的神经退行症的原因.
- 该研究扩大了TTC19相关疾病的范围,并强调了基因异质性和变异的区域聚类.
- 这些发现强调了在患有不明原因的神经退行性表型的患者中对TTC19进行遗传检测的重要性.
相关概念视频
Animal Mitochondrial Genetics
9.9K
Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
9.9K
Electron Transport Chain: Complex III and IV
9.6K
During the electron transport chain, electrons from NADH and FADH2 are first transferred to complexes I and II, respectively. These two complexes then transfer the electrons to ubiquinol, which carries them further to complex III. Complex III passes the electrons across the intermembrane space to Cyt c, which carries them further to complex IV. Complex IV donates electrons to oxygen and reduces it to water. As electrons pass through complexes I, III, and IV, the energy released aids the pumping...
9.6K
Electron Transport Chain: Complex I and II
19.4K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
19.4K
Cardiomyopathy III: Hypertrophic Cardiomyopathy
611
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
611
ATP Synthase: Mechanism
18.3K
In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased...
18.3K
The Supercomplexes in the Crista Membrane
3.1K
The mitochondrial cristae membrane is the primary site for the oxidative phosphorylation (OXPHOS) process of energy conversion mediated through respiratory complexes I to V. These complexes have been widely studied for decades, and it has been proven that they form supramolecular structures called respiratory supercomplexes (SC). These higher-order complexes may be crucial in maintaining the biochemical structure and improving the physiological activity of the individual complexes while...
3.1K


